Double-rnonoclonal immunofluorometric assays for pregnancy-associated plasma protein A/proeosinophil major basic protein (PAPP-A/proMBP) complex in first-trimester maternal serum screening for down syndrome

Clinical Chemistry

Volumn 43, Issue 12, 1997, Pages 2323-2332

  Qin, Qiu Ping ^a   Christiansen, Michael ^a   Oxvig, Claus ^a   Pettersson, Kim ^b   Sottrup Jensen, Lars ^a   Koch, Claus ^c   Nørgaard Pedersen, Bent ^a  

^a STATENS SERUM INSTITUT   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c UNIVERSITY OF TURKU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR BASIC PROTEIN; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; BIOLOGICAL MARKER; PLASMA PROTEIN; PREGNANCY ASSOCIATED PLASMA PROTEIN A; PRG2 PROTEIN, HUMAN; PROTEOGLYCAN;

ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DOWN SYNDROME; EARLY DIAGNOSIS; FLUOROMETRY; KARYOTYPING; PRENATAL DIAGNOSIS; PRENATAL SCREENING; BLOOD; COMPARATIVE STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; FLUOROIMMUNOASSAY; GEL CHROMATOGRAPHY; HUMAN; IMMUNOLOGY; METHODOLOGY; PREGNANCY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ANTIBODIES, MONOCLONAL; BIOLOGICAL MARKERS; BLOOD PROTEINS; CHROMATOGRAPHY, GEL; DOWN SYNDROME; FEMALE; FLUOROIMMUNOASSAY; HUMANS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PRENATAL DIAGNOSIS; PROTEOGLYCANS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 0031283462     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/43.12.2323     Document Type: Article

References (41)

1. Tabor A, Philip J, Madsen M, Obel EB, Nørgaard-Pedersen B. Randomised controlled trial of genetic amniocentesis in 4606 low risk women. Lancet 1986;i:1287-93.
2. Firth HV, Boyd PA, Chamberlain PF, Mackenzie IZ, Morriss-Kay GM Huson SM. Analysis of limb reduction defects in babies exposed to chorionic villus sampling. Lancet 1994;343:1069-71.
3. Nicolaides K, Brizot ML, Patel F, Snijders R. Comparison of chorionic villus sampling and amniocentesis for fetal karyotyping at 10-13 weeks' gestation. Lancet 1994;344:435-9.
4. Rousseau O, Boulot P, Lefort G, Nagy P, Bachelard B, Bonifacj C, et al. Amniocentesis before 15 weeks' gestation: technical aspects and obstetric risks. Eur J Obstet Gynecol Reprod Biol 1995;58:127-30.
5. Crandall BF, Kulch P, Tabsh K. Risk assessment of amniocentesis between 11 and 15 weeks: comparison to later amniocentesis controls. Prenat Diagn 1994;14:913-9.
6. Eiben B, Goebel R, Hansen S, Hammans W. Early amniocentesis - a cytogenetic evaluation of over 1500 cases. Prenat Diagn 1994;14:497-501.
7. Wald NJ, Densem JW, Smith D, Klee GG. Four-marker serum screening for Down's syndrome. Prenat Diagn 1994;14:707-16.
8. Spencer K, Aitken DA, Crossley JA, McCaw G, Berry E, Anderson R, et al. First trimester biochemical screening for trisomy 21: the role of free beta hCG, alpha fetoprotein and pregnancy associated plasma protein A. Ann Clin Biochem 1994;31:447-54.
9. Brambati B, Tului L, Bonacchi I, Shrimanker K, Suzuki Y, Grudzinskas JG. Serum PAPP-A, free β-hCG are first-trimester screening markers for Down syndrome. Prenat Diagn 1994;14:1043-7.
10. Macintosh MCM, Iles R, Teisner B, Sharma K, Chard T, Grudzinskas JG, et al. Maternal serum human chorionic gonadotrophin and pregnancy-associated plasma protein A: markers for fetal Down syndrome at 8-14 weeks. Prenat Diagn 1994;14:203-8.
11. 1-glycoprotein in fetal trisomies. Br J Obstet Gynaecol 1994;101:970-4.
12. Qin QP, Nguyen TH, Christiansen M, Larsen SO, Nørgaard-Pedersen B. Time-resolved immunofluorometric assay of pregnancy-associated plasma protein A in maternal serum screening for Down's syndrome in first trimester of pregnancy. Clin Chim Acta 1996;254:113-29.
13. Wald NJ, George L, Smith D, Densem JW, Pettersson K. Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy. Br J Obstet Gynecol 1996;103:407-12.
14. Wald NJ, Densem JW, George L, Muttukrishna S, Knight PG. Prenatal screening for Down's syndrome using inhibin-A as a serum marker. Prenat Diagn 1996;16:143-53.
15. Macintosh MCM, Brambati B, Chard T, Grudzinskas JG. First trimester maternal serum SP1 in pregnancies associated with chromosomal anomalies. Prenat Diagn 1993;13:563-8.
16. Qin QP, Christiansen M, Nguyen TH, Sørensen S, Larsen SO, Nørgaard-Pedersen B. Schwangerschaftsprotein 1 (SP1) as maternal serum marker for Down's syndrome in first and second trimester. Prenat Diagn 1997;17:101-8.
17. 3 and AFP in fetal Down's syndrome. Prenat Diagn 1991;11:377-80.
18. Wald NJ, Kennard A, Hackshaw AK. First trimester serum screening for Down's syndrome. Prenat Diagn 1995;15:1227-40.
19. Oxvig C, Sand O, Kristensen T, Kristensen L, Sottrup-Jensen L. Isolation and characterization of circulating complex between human pregnancy-associated plasma protein-A and proform of eosinophil major basic protein. Biochim Biophys Acta 1994;1201: 415-23.
20. Bischof P, Haenggeli L, Sizonenko MT, Herrmann WC, Sizonenko PC. A radioimmunoassay for the measurement of pregnancy-associated plasma protein-A (PAPP-A) in humans. Biol Reprod 1981;24:1076-81.
21. Sinosich MJ, Teisner B, Folkersen J, Saunders DM, Grudzinskas JG. Radioimmunoassay for pregnancy-associated plasma protein-A. Clin Chem 1982;28:50-3.
22. Bersinger NA, Zakher A, Huber U, Pescia G, Schneider H. A sensitive enzyme immunoassay for pregnancy associated plasma protein A: a possible first trimester method of screening for Down syndrome and other trisomies. Arch Gynecol Obstet 1995;256: 185-92.
23. Ruge S, Pedersen JF, Sørensen S, Lange AP. Can pregnancy-associated plasma protein A (PAPP-A) predict the outcome of pregnancy in women with threatened abortion and confirmed fetal viability? Acta Obstet Gynecol Scand 1990;69:589-95.
24. Oxvig C, Haaning J, Kristensen L, Wagner JM, Rubin I, Stigbrand T, et al. Identification of angiotensinogen and complement C3dg as novel proteins binding proform of eosinophil major basic protein in human pregnancy serum and plasma. J Biol Chem 1995;270: 13645-51.
25. Bueler MR, Bersinger NA. Antiserum to pregnancy associated plasma protein A (PAPP-A) recognizes human haptoglobin. Br J Obstet Gynaecol 1989;96:867-9.
26. Qin QP, Christiansen M, Oxvig C, Yazova AK, Jaliachvili I, Pettersson K, et al. Monoclonal antibodies against the complex of human pregnancy-associated plasma protein-A and the proform of eosinophil major basic protein (PAPP-A/proMBP-complex): production, characterization, epitope analysis and application in immunochemical assays for PAPP-A/proMBP-complex [Abstract]. Recent Advances in Prenatal Diagnosis for Aneuploidy, 1-3 May 1996, Amsterdam; p13.
27. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine [Review]. Clin Chem 1993;39:561-77.
28. Lin TM, Halbert SP, Spellacy WN. Measurement of pregnancy-associated plasma proteins during human gestation. J Clin Invest 1974;54:576-82.
29. Bishof P, Bruce D, Cunningham P, Klopper A. Measurement of pregnancy-associated plasma protein-A (PAPP-A) during the ovulatory menstrual cycle. Br J Obstet Gynecol 1979;91:1245-8.
30. Folkersen J, Grudzinskas JG, Hindersson P, Teisner B, Westergaard JG. Pregnancy-associated plasma protein-A: circulating levels during normal pregnancy. Am J Obstet Gynecol 1981;139: 910-4.
31. Anthony F, Masson GM, Wood PJ. Development of a radioimmunoassay for pregnancy-associated plasma protein-A and establishment of normal levels in the first trimester of pregnancy. Ann Clin Biochem 1983;20:26-30.
32. Pinto-Furtado LG, Button AE, Grudzinskas JG, Chapman MG, Sinosich MJ, Sharma V. The development and validation of a radioimmunoassay for human pregnancy-associated plasma protein-A (PAPP-A). Arch Gynecol 1984;236:83-92.
33. Mowles EA, Pinto-Furtado LG, Bolton AE. A two-site immunoradiometric assay for human pregnancy-associated plasma protein A (PAPP-A) using monoclonal antibodies. J Immunol Methods 1986; 95:129-33.
34. Pledger DR, Belfied A. An ELISA for pregnancy-associated plasma protein-A. Ann Clin Biochem 1983;20:236-40.
35. Bersinger N. Two-site enzyme immunoassay for pregnancy-associated plasma protein A (PAPP-A). Clin Chim Acta 1983;143:297-306.
36. MacDonald DJ, Mehta HC, Mack DS, Duffy T, Glen ACA. Enzyme immunoassay for pregnancy-associated plasma protein-A. Clin Chem 1984;30:1848-50.
37. Chemnitz J, Folkersen B, Teisner B, Sinosich MJ, Tornehave D, Westergaard JG, et al. Comparison of different antibody preparations against pregnancy-associated plasma protein-A (PAPP-A) for use in localization and immunoassay studies. Br J Obstet Gynecol 1986;93:916-23.
38. Bischof P. Three pregnancy proteins (PP12, PP14, and PAPP-A): their biological and clinical relevance. Am J Perinatol 1989;6: 110-6.
39. Haaning J, Oxvig C, Overgaard MT, Ebbesen P, Kristensen T, Sottrup-Jensen L. Complete cDNA sequence of the preproform of human pregnancy-associated plasma protein-A. Evidence for expression in the brain, and induction by cyclic AMP. Eur J Biochem 1996;237:159-63.
40. Bischof P, Meisser A. Immunological heterogeneity of pregnancy-associated plasma protein-A (PAPP-A). Effects on the radioimmunoassay of PAPP-A. Br J Obstet Gynecol 1989;96:870-5.
41. Oxvig C, Haaning J, Hojrup P, Sottrup-Jensen L. Location and nature of carbohydrate groups in proform of human major basic protein isolated from pregnancy serum. Biochem Mol Biol Int 1994;33:329-36.